MeSH term
Frequency | Condition_Probility | Amino Acid Sequence | 9 | 0.0 |
Animals | 16 | 0.0 |
Humans | 57 | 0.0 |
Molecular Sequence Data | 12 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Sequence Homology | 2 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Adult | 14 | 0.0 |
African Continental Ancestry Group/*genetics | 3 | 1.0 |
Aged | 11 | 0.0 |
Alleles | 3 | 0.0 |
Female | 25 | 0.0 |
Male | 25 | 0.0 |
Middle Aged | 15 | 0.0 |
*Polymorphism, Genetic | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 24 | 0.0 |
*Variation (Genetics) | 2 | 0.0 |
Blotting, Northern | 5 | 0.0 |
Cells, Cultured | 6 | 0.0 |
In Situ Hybridization | 3 | 0.0 |
Oligonucleotide Array Sequence Analysis | 5 | 0.0 |
Pregnancy | 4 | 0.0 |
RNA, Messenger/biosynthesis/genetics | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 43 | 0.0 |
Apolipoproteins/genetics/*metabolism | 5 | 50.0 |
Gene Expression | 7 | 0.0 |
Immunohistochemistry | 6 | 0.0 |
Ligands | 5 | 0.0 |
Apolipoproteins/*biosynthesis | 3 | 33.0 |
Gene Expression Regulation | 2 | 0.0 |
Mice | 6 | 0.0 |
Apolipoproteins/*metabolism | 7 | 17.0 |
Apolipoproteins E/*metabolism | 2 | 1.0 |
Base Sequence | 7 | 0.0 |
Cell Division | 2 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
Exons | 2 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
RNA, Messenger/*metabolism | 2 | 0.0 |
Time Factors | 3 | 0.0 |
Transfection | 3 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Up-Regulation | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Comparative Study | 10 | 0.0 |
Lod Score | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Alzheimer Disease/*genetics | 2 | 0.0 |
Apolipoproteins/*genetics | 9 | 13.0 |
Case-Control Studies | 3 | 0.0 |
Gene Frequency | 2 | 0.0 |
Genotype | 5 | 0.0 |
Analysis of Variance | 2 | 0.0 |
Apolipoproteins/*blood/metabolism | 2 | 100.0 |
Blotting, Western | 4 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 4 | 0.0 |
Recombinant Fusion Proteins/biosynthesis/chemistry | 2 | 10.0 |
Aged, 80 and over | 5 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Rats | 3 | 0.0 |
Sheep | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
Hippocampus/*metabolism | 2 | 2.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Antineoplastic Agents/pharmacology | 2 | 0.0 |
Cycloheximide/pharmacology | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Fibrocystic Breast Disease/metabolism | 2 | 33.0 |
*Glycoproteins | 2 | 0.0 |
Chromatography, Affinity | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 4 | 0.0 |
Immunoelectrophoresis | 2 | 0.0 |
Cell Division/drug effects | 2 | 0.0 |
Tretinoin/*pharmacology | 2 | 0.0 |
Glycosylation | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
Rabbits | 4 | 0.0 |
Transcription, Genetic | 4 | 0.0 |
Arachidonic Acid/*metabolism | 2 | 5.0 |
Cholesterol/metabolism | 2 | 0.0 |
In Vitro | 2 | 0.0 |
Phosphatidylcholine-Sterol O-Acyltransferase/metabolism | 2 | 3.0 |
Gestational Age | 2 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Disulfides/*chemistry | 2 | 5.0 |
*Gene Expression Profiling | 2 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
Cell Line | 4 | 0.0 |
Lipids/analysis | 2 | 4.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Gene Expression Regulation/drug effects | 2 | 0.0 |
Risk Factors | 2 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Apolipoproteins/*blood | 3 | 1.0 |
Cholesterol/blood | 4 | 0.0 |
Cholesterol Esters/blood | 2 | 1.0 |
Lipids/*blood | 2 | 0.0 |
Lipoproteins, HDL/blood | 2 | 0.0 |
Lipoproteins, LDL/blood | 3 | 1.0 |
Lipoproteins, VLDL/blood | 3 | 1.0 |
Triglycerides/blood | 3 | 0.0 |
Biological Markers/analysis | 2 | 0.0 |
Phospholipids/blood | 2 | 1.0 |
Infant, Newborn | 2 | 0.0 |
